📰 John Arnone News
John Arnone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Arnone. Real-time updates on events, politics, business and more.
October 4, 2023
After fifteen years, Tommy Tune and Larry L. King are at it again: The sequel to the most famous musical about our state opens on Broadway.
January 6, 2023
Eatontown, New Jersey--(Newsfile Corp. - January 6, 2023) - American CryoStem Corporation (OTC Pink: CRYO), a clinical-stage therapeutics company with a proprietary end-to-end core biotechnology platform
November 2, 2022
The vintage Pepsi sign is down, but not gone. By next summer, it will have a new home.
March 24, 2022
John Arnone was nine and on a bakery run for his grandmother when he fell head over heels in love with The Beatles.
March 17, 2022
In Danville, there are a few places to get ice cream, including Dairy Queen, sweetFrog and Hopper’s Poppers, but there is only one that has been a tradition for more
December 30, 2021
Ref: "Refugees, not Migrants", Letters, yesterday.
May 6, 2021
American CryoStem Executes LOI with Advanced Regenerative Associates to Conduct Wound Healing Clinical Study ACCESSWIRE 06 May 2021, 15:05 GMT+10 EATONTOWN, NJ / ACCESSWIRE / May 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and therapies announced today, that it has signed a Letter of Intent (LOI) with Advanced Regenerative Associates, LLC (ARA) of Tinton Falls, NJ for the develop...
May 6, 2021
EATONTOWN, NJ / ACCESSWIRE / May 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and therapies
February 25, 2021
(2) EATONTOWN, NJ / ACCESSWIRE / February 25, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida. CRYO will optimize cell recovery from the umbilical cord to supply umbilical cord cells u...
January 6, 2021
(1) EATONTOWN, NJ / ACCESSWIRE / January 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology Company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) authorized by published code 15 U.S.C. 3710a of US Title 15 Commerce and Trade. (https://www.disa.mil/about/cto/crada-process-overview ) The Collaborative work will be conducted at the ...